Drug intelligence / Profile preview

quinine

Development stage
Approved
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral, Intravenous
01

Overview

Quinine is a naturally occurring alkaloid derived from the bark of the cinchona tree and is primarily used as an antimalarial drug. It is indicated for the treatment of uncomplicated malaria caused by *Plasmodium falciparum*, especially in cases where resistance to other antimalarials such as chloroquine exists[1][3][5]. Quinine may also be used to treat babesiosis. Its mechanism of action involves interfering with the parasite's ability to metabolize hemoglobin by inhibiting nucleic acid synthesis, protein synthesis, and glycolysis in *Plasmodium* species[6][7]. The most widely accepted hypothesis suggests that quinine inhibits hemozoin biocrystallization in the parasite’s food vacuole, leading to accumulation of cytotoxic heme and subsequent death of the parasite[7][8]. Quinine has also been historically used as a mild antipyretic and analgesic but is not approved for nocturnal leg cramps due to safety concerns[2].

Brand names
QualaquinQuinammQuinbisul
Other names
quinine hydrochloridequinine HCl
02

Targets

HTR3A (5-hydroxytryptamine receptor 3A)PfPNP (Plasmodium falciparum purine nucleoside phosphorylase)GPIIb/IIIa (Integrin alpha-IIb/beta-3)β-HematinDNA

Beyond the preview

Go deeper on quinine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on quinine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call